Az angiogenezis gátlásának szerepe a vastagbél-és végbélrák kezelésé ben

Translated title of the contribution: Role of angiogenesis inhibitors in the treatment of colorectal cancer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In our time, molecular targeted therapy plays a key role in the modern therapy of solid tumors. Of these modalities, in colorectal cancer monoclonal antibodies are introduced in routine use. In our article we provide an overview of the mechanism of action, place in treatment and efficacy of bevacizumab, an angiogenic inhibitor.

Translated title of the contributionRole of angiogenesis inhibitors in the treatment of colorectal cancer
Original languageHungarian
Pages (from-to)139-144
Number of pages6
JournalMagyar onkologia
Volume51
Issue number2
Publication statusPublished - Dec 1 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Role of angiogenesis inhibitors in the treatment of colorectal cancer'. Together they form a unique fingerprint.

  • Cite this